2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… mais…
booklooker.de buecher.de GmbH & Co. KG Custos de envio:Versandkostenfrei, Versand nach Deutschland. (EUR 0.00) Details... |
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - encadernada, livro de bolso
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … mais…
booklooker.de |
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - encadernada, livro de bolso
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … mais…
booklooker.de |
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - encadernada, livro de bolso
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … mais…
booklooker.de |
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… mais…
Achtung-Buecher.de MARZIES.de Buch- und Medienhandel, 14621 Schönwalde-Glien Custos de envio:Versandkostenfrei innerhalb der BRD. (EUR 0.00) Details... |
2012, ISBN: 9782817803357
[ED: Hardcover], [PU: Springer / Springer Paris / Springer, Berlin], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but als… mais…
Prugnaud, Jean-Louis:
Biosimilars | A New Generation of Biologics | Jean-Louis Prugnaud (u. a.) | Buch | Englisch | 2012 | Springer Paris | EAN 9782817803357 - encadernada, livro de bolso2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … mais…
Biosimilars / A New Generation of Biologics / Jean-Louis Prugnaud (u. a.) / Buch / Englisch / 2012 / Springer Paris / EAN 9782817803357 - encadernada, livro de bolso
2012
ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … mais…
Biosimilars A New Generation of Biologics Jean-Louis Prugnaud (u. a.) Buch Englisch 2012 Springer Paris EAN 9782817803357 - encadernada, livro de bolso
2012, ISBN: 9782817803357
[ED: Gebunden], [PU: Springer Paris], Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high … mais…
2013, ISBN: 2817803353
Gebundene Ausgabe Arznei - Arzneimittel, Medikament, Pharmaka, Tablette, Immunsystem - Immunologie - Immun - Autoimmunität, Krebs (Krankheit) / Onkologie, Onkologie - Radioonkologie, Med… mais…
Dados bibliográficos do melhor livro correspondente
Autor: | |
Título: | |
Número ISBN: |
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities.
In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature.
This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the Eu
Dados detalhados do livro - Biosimilars
EAN (ISBN-13): 9782817803357
ISBN (ISBN-10): 2817803353
Livro de capa dura
Ano de publicação: 20121130
Editor/Editora: Springer Editions
87 Páginas
Peso: 0,343 kg
Língua: Englisch
Livro na base de dados desde 2007-02-10T15:10:29-02:00 (Sao Paulo)
Página de detalhes modificada pela última vez em 2022-08-19T06:29:49-03:00 (Sao Paulo)
Número ISBN/EAN: 9782817803357
Número ISBN - Ortografia alternativa:
2-8178-0335-3, 978-2-8178-0335-7
Ortografia alternativa e termos de pesquisa relacionados:
Autor do livro: jean hugues, john seymour, louis
Título do livro: leben auf dem lande
Dados da editora
Autor: Jean-Louis Prugnaud; Jean-Hugues Trouvin
Título: Biosimilars - A New Generation of Biologics
Editora: Springer; Springer Paris
90 Páginas
Ano de publicação: 2012-11-21
Paris; FR
Impresso / Feito em
Peso: 0,336 kg
Língua: Inglês
128,39 € (DE)
131,99 € (AT)
142,00 CHF (CH)
POD
XVIII, 90 p.
BB; Oncology; Hardcover, Softcover / Medizin/Klinische Fächer; Onkologie; Verstehen; Biomedicine; Biosimilars; Cost; Immunogenicity; Interchangeability; Nephrology; Pharmacy; Pharmaceutical Sciences/Technology; Immunology; Oncology; Nephrology; Pharmacy; Pharmaceutics; Immunology; Nierenheilkunde, Nephrologie; Pharmazie, Apotheke; Medizinische Chemie, Pharmazeutische Chemie; Immunologie; BC; EA
Biologics have revolutionised the treatment of many severe conditions, delivering exceptional clinical results but also producing exceptionally high prices. As patents expire, copies and price competition are expected throughout the world. However, due to the intrinsic heterogeneity and molecular complexity of biologic medicinal products, their copies cannot simply be authorized under the “generic rule” valid for small chemical entities. In response, a dedicated regulation was issued in the European Union. It is based on the concept of “biological medicinal products similar to a biological reference product”, or “biosimilars”. This book analyses the context of biotechnological production and addresses the European legal framework for biosimilar market approval. It highlights post-market authorisation issues, such as Risk Management Plans and substitution of products, and outlines some other issues, such as cost management and international nomenclature. This book is primarily intended for hospital-based physicians and pharmacists. It will also be a valuable resource for all actors from all countries who want to better understand the emergence of these new medicinal products within the European context.Outros livros adicionais, que poderiam ser muito similares com este livro:
Último livro semelhante:
9782817805146 Biosimilars (Jean-Louis Prugnaud; Jean-Hugues Trouvin)
< Para arquivar...